Pesticide free lice treatments make their entrance as recommendations from the Canadian Paediatric Society

Wednesday, September 28, 2016 Child Health News
Email Print This Page Comment bookmark
Font : A-A+

The Canadian Paediatric Society new guidelines recognize the effectiveness of pesticide free lice treatments.

MONTRÉAL, Sept. 28, 2016

/CNW Telbec/ - Pediapharm welcomes the introduction of pesticide free lice treatments in the Canadian Paediatric Society new guidelines recently updated for the first time in eight years. These new recommendations represent the first step towards the
awareness of the adverse effects of neurotoxic substances on children. Such awareness is truly important, especially now as the general public and members of the medical community worry about the risks associated with the use of neurotoxic substances.

''We are very pleased that the Canadian Paediatric Society recognizes the effectiveness of dimeticone-based products, such as NYDA®, to kill lice and eggs while ensuring a safe pediculosis treatment, claims Sylvain Chrétien, former President and Chief Executive at Pediapharm. NYDA® is a dimeticone based product that has a physical mode of action which makes it sought by parents and clinicians".  

Dimeticone, unlike all insecticide substances, has been recognized as one of the few products with low risk of irritation and no risk of resistance. The Society "takes into account the growing resistance of lice" to pyrethrin and to permethrine (pesticides) as well as the alarming amount of over diagnosis.

"Through my professional practice I regularly speak with parents who struggle to get rid of head lice using the common pesticide treatments, added Sherry Torkos, pharmacist and author of The Canadian Encyclopedia of Natural Medicine1. Parents are also concerned with the possible risks and side effects. I am happy to see that the Canadian Pediatric Society has included a safe and efficacious non-pesticide treatment option in their guidelines."

Lice as a social issueIt is worth noting that lice infestation is an undesirable transmitted public health issue particularly for school aged children. Unlike body lice, head lice are not a symbol of poor hygiene but an actual social issue since it is spread by direct hair to hair contact. The infested children are generally carrying less than 20 lice that, without treatment, could each live up to three or four weeks.

About NYDA pesticide-free treatmentNYDA® is a head lice treatment solution by Pediapharm, an industry leader in paediatric pharmaceuticals in Canada. It is made from dimeticone 100 cSt, which penetrates the lice's' respiratory system, making it effective against pesticide-resistant lice and safe for children's skin2. Public health authorities recommend limiting the use of pesticides because of the dangers they pose to children's health.

About PediapharmPediapharm is the first and only specialty pharmaceutical corporation in Canada that exclusively distributes and licenses innovative medicines in order to help improve children's health and quality of life.Through its network's ownership of the key stakeholders within the pediatric arena, Pediapharm's key objective is to partner with leading healthcare entities around the world to bring innovative pediatric products to the Canadian market.

Its portfolio of innovative products include NYDA®, a revolutionary  treatment against head lice; EpiCeram, a ?non-steroidal cream used to treat eczema; Naproxen suspension, used for pain and inflammation caused by various medical conditions such as juvenile arthritis; and various other registered products.  

1 Sherry Torkos (2013), The Canadian Encyclopedia of Natural Medicine (2nd edition), Toronto: Harper Colins Publishers.

2 Heukelbach J, Pilger D, liveira FA, Khakban A, Ariza L, Feldmeier H, A highly efficacious pediculicide based on dimeticone: randomized observer blinded comparative trial. BMC Infectious Diseases, 2008; 8:115.


SOURCE Pediapharm Inc.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store